在糖尿病治疗中探索多功能生物聚合物聚酸酸盐
Gunjan Adwani1, Sharda Bharti1, Awanish Kumar1
1Department of Biotechnology, National Institute of Technology, Raipur, Chhattisgarh, India.
Journal of biomaterials science. Polymer edition
|May 29, 2025
概括
聚氨基酸 (PHAs) 作为糖尿病管理的生物材料具有前景,可提供可控的药物输送和伤口愈合. 需要进一步的研究来克服生产挑战,并充分发挥其治疗潜力.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病是一种全球性的慢性代谢疾病,其特征是高血糖症.
- 目前糖尿病的治疗需要非侵入性胰岛素输送和有效的伤口愈合疗法.
- 对于提高糖尿病管理的新生物材料有很大的需求.
研究的目的:
- 审查Polyhydroxyalkanoates (PHAs) 在糖尿病管理中的治疗潜力.
- 探索PHAs作为先进生物材料的应用,用于抗糖尿病和伤口愈合疗法.
- 突出在糖尿病护理中PHA利用的挑战和未来方向.
主要方法:
- 文献综述侧重于生物医学应用中的多基酸盐 (PHAs).
- 对PHA属性的分析,包括生物相容性,生物降解性和受控的药物释放.
- 检查PHA在生物人工胰腺发育和伤口愈合中的应用.
主要成果:
- PHAs具有生物相容性,生物降解性,并且可以合成成支架和纳米材料,用于持续的药物输送.
- PHAs表现出抗糖尿病和抗微生物活性,有利于伤口愈合.
- 基于PHA的支架为生物人工胰腺设计中的胰腺细胞封装提供了支持的环境.
结论:
- PHAs为开发先进的糖尿病疗法提供了一个多功能平台,包括控制胰岛素输送和改善伤口愈合.
- 诸如高生产成本和市场整合等挑战需要进一步调查.
- 持续的研究对于充分利用PHAs的治疗能力来全面管理糖尿病至关重要.
相关概念视频
Glucagon-like Receptor Agonists
854
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
854
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
526
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
526
Dipeptidyl Peptidase 4 Inhibitors
598
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
598
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K


